Shue‐Fen Luo

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families

Chang‐Fu Kuo, Matthew J. Grainge, Ana M. Valdes et al. · JAMA Internal Medicine · 2015 · 308 citations · Full text

Life Sciences, Genetics, Immunology +17

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis

Brad H. Rovin, Neil Solomons, William F. Pendergraft et al. · Kidney International · 2018 · 304 citations

Medicine, Nephrology, Pharmacology +8

Gout: an independent risk factor for all-cause and cardiovascular mortality

Chang‐Fu Kuo, Lai‐Chu See, Shue‐Fen Luo et al. · Lara D. Veeken · 2009 · 234 citations · Full text

Public Health, Health Sciences, Preventive Medicine +16

Dehydroepiandrosterone treatment of women with mild‐to‐moderate systemic lupus erythematosus: A multicenter randomized, double‐blind, placebo‐controlled trial

Deh‐Ming Chang, Joung‐Liang Lan, Hsiao‐Yi Lin et al. · Arthritis & Rheumatism · 2002 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9